Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
04/1998
04/01/1998EP0832981A1 DNA sequences to target proteins to the mammary gland for efficient secretion
04/01/1998EP0832891A1 Dihydrobenzo (B) indeno (2,1-D) thiophene compounds, intermediates, processes, compositions, and methods
04/01/1998EP0832107A1 An improved peptide, immunogenic composition and vaccine or medical preparation, a method to immunise animals against the hormone lhrh, and analogs of the lhrh tandem repeat peptide and their use as vaccine
04/01/1998EP0832099A1 Reversible cysteine protease inhibitors
04/01/1998EP0832082A1 N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists
04/01/1998EP0832061A1 Benzamide derivatives and their use as vasopressin antagonists
04/01/1998EP0831864A1 Processed ginseng having enhanced pharmacological effect
04/01/1998EP0831858A1 Intrauterine chemical necrosing method and composition
04/01/1998EP0831829A1 Heterocyclic ring-fused pyrimidine derivatives
04/01/1998EP0831822A1 Calcium channel antagonists
04/01/1998EP0831791A1 Delivery of drugs to the lower gi tract
04/01/1998EP0741707B1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS
04/01/1998CN1177909A Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
03/1998
03/31/1998US5733902 Compounds having antiprogestational and anti-estrogenic activities for the treatment of hormone-dependent tumors
03/31/1998US5733872 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
03/31/1998US5733565 Male contraceptive implant
03/31/1998US5733562 Injectable medical device and method of use
03/31/1998US5733540 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
03/31/1998CA2134889C Calcium channel blocking polypeptides from filistata hibernalis
03/26/1998CA2214176A1 Dihydrobenzo[b]indeno[2,1-d]thiophene compounds, intermediates, processes, compositions and methods
03/25/1998EP0831089A1 Benzothiophene compounds, intermediates, processes, compositions, and methods
03/25/1998EP0830136A1 New cryptophycins from synthesis
03/25/1998EP0830130A1 Tnf-alpha converting enzyme
03/25/1998EP0628040B1 Indole derivatives as steroid 5 alpha-reductase inhibitors
03/25/1998CN1177356A Bicyclic benzazepine derivatives as vasopressin antagonists
03/25/1998CN1177303A Application of lysozyme dimer
03/25/1998CN1177297A Medicament interded to the treatment of obsessive compulsive troubles, sleep apnoea, sexual dysfuctions emesa and transport sickness
03/25/1998CN1177294A Water based topical cream contg. nitroglycerin, prepn. method therefor and use thereof
03/25/1998CN1176811A Drug compositions for preventing and treating gonorrhoea and syphilis
03/25/1998CN1176799A Drug for treating sexual impotence
03/25/1998CN1176794A Medicine for treating masculine sterility
03/24/1998USRE35752 As an aqueous solution along eith dextrose
03/24/1998US5731350 Substituted benzenedicarboxylic acid diguanides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
03/24/1998US5731339 Administering vasodilator; phentolamine mesylate or hydrochloride
03/24/1998US5731327 Synthesis of 3- 4-(2-aminoethoxy)benzoyl!-2-aryl-6-hydroxybenzo b!thiophenes
03/24/1998US5731321 Endothelin receptor antagonists
03/24/1998US5731293 Enzyme inhibitors
03/24/1998US5731286 Cyclic neurokinin A antagonists
03/24/1998CA2214919A1 Benzothiophene compounds, intermediates, processes, compositions, and methods
03/19/1998WO1998011089A1 Novel benzothiophene derivatives, their preparation and use as urokinase inhibitors
03/19/1998WO1998010791A1 Materials and methods relating to the diagnosis and treatment of pre-eclampsia and diabetes
03/19/1998WO1998010783A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions
03/19/1998WO1998010765A1 Non-hormonal method of contraception
03/19/1998CA2265495A1 Non-hormonal method of contraception
03/19/1998CA2264748A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions
03/18/1998EP0829480A2 Tetrazolyl-substituted quinuclidines as substance P antagonists
03/18/1998EP0829263A1 Use of 8,9-dehydroestrone in estrogen therapy
03/18/1998EP0829262A2 Use of PKC inhibitors for the manufacture of a medicament for the treatment of sexual dysfunctions
03/18/1998EP0828724A1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors
03/18/1998EP0828712A1 Beta-adrenergic agonists
03/18/1998EP0828500A1 Use of flavanolignanes for the preparation of medicaments with antiproliferative activity in uterus, ovary and breast
03/18/1998CN1176600A Method for inhibiting ovarian cancer
03/17/1998US5728819 Secreted proteins and polynucleotides encoding them
03/17/1998US5728738 Mixing alkali with sodium mercaptoethylsulfonate
03/17/1998US5728724 Treatment of postmenopause syndrome, osteoporosis, cardiovascular disorders and estrogen dependent cancer
03/17/1998US5728689 11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
03/17/1998US5728688 Therapeutic methods and delivery systems utilizing sex steroid precursors
03/17/1998US5728678 Method and composition for providing nutrition to a renal failure patient
03/16/1998CA2215655A1 Use of 8,9-dehydroestrone as an estrogen with neutral effects on prolactin levels
03/12/1998WO1998009980A1 Bh3 interacting domain death agonist
03/12/1998WO1998009963A1 Amorphous paroxetine composition
03/12/1998WO1998005792A3 A novel human leptin receptor gene-related protein
03/12/1998CA2264578A1 Bh3 interacting domain death agonist
03/11/1998EP0827959A2 Benzo[B]thiophene compounds, intermediates, processes, compositions, and methods
03/11/1998EP0827511A1 Agents for binding to advanced glycosylation endproducts, and methods of their use
03/11/1998EP0827505A1 Selected soluble esters of hydroxyl-containing indolocarbazoles
03/11/1998EP0827408A1 Method of administration of igf-i
03/11/1998EP0827401A2 Methods and compositions for inhibiting alpha-reductase activity
03/11/1998EP0696919A4 Diagnosis and treatment of erectile dysfunction
03/11/1998EP0636125B1 Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists
03/11/1998CN1175456A Traditional Chinese medicine composition for treatment of female dysgenesis
03/10/1998US5726205 O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as a method of preparing them
03/10/1998US5726202 Benign prostatic hypertrophy
03/10/1998US5726196 Aromatase-inhibiting composition containing azole derivative
03/10/1998US5726156 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
03/10/1998US5726149 Treatment of glomerulonephritis with decorin
03/10/1998US5725858 Methods of enhancing production performance of birds comprising administration of heterologous protein comprising avian alpha-subunit inhibin protein
03/05/1998WO1998009170A2 Methods and compositions for the detection of cervical cancer
03/05/1998WO1998008864A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE
03/05/1998WO1998008850A1 Spirocyclic metalloprotease inhibitors
03/05/1998WO1998008847A1 Substituted 6,5-hetero-bicyclic derivatives
03/05/1998WO1998008846A1 Substituted 6,6-hetero-bicyclic derivatives
03/05/1998WO1998008827A1 Heterocyclic metalloprotease inhibitors
03/05/1998WO1998008826A1 Piperazino derivatives as neurokinin antagonists
03/05/1998WO1998008825A1 1,4-heterocyclic metalloprotease inhibitors
03/05/1998WO1998008533A1 Sustained peptide-release formulation
03/05/1998WO1998008525A1 Process to obtain oestrogens from mare's urine
03/05/1998WO1998008513A1 Amorphous benzothiophenes, methods of preparation, and methods of use
03/05/1998WO1998002452A3 Compounds and methods for modulating cell adhesion
03/05/1998WO1997037688A3 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity
03/05/1998CA2264045A1 Heterocyclic metalloprotease inhibitors
03/05/1998CA2264044A1 Spirocyclic metalloprotease inhibitors
03/05/1998CA2263932A1 1,4-heterocyclic metalloprotease inhibitors
03/05/1998CA2263827A1 Fibroblast growth factor homologous factors (fhfs) and methods of use
03/05/1998CA2263175A1 Amorphous benzothiophenes, methods of preparation, and methods of use
03/04/1998EP0826683A1 Benzo[B]thiophene compounds, intermediates, processes, compositions, and methods
03/04/1998EP0826682A1 Amorphous benzothiophenes, methods of preparation, and methods of use
03/04/1998EP0826680A1 Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods
03/04/1998EP0826670A1 Naphthalene compounds, intermediates, formulations, and methods
03/04/1998EP0825993A1 Xanthines and their therapeutic use
1 ... 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 ... 557